Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ADRA1D anticorps (N-Term)

L’anticorps Lapin Polyclonal anti-ADRA1D a été validé pour WB, IHC (p) et FACS. Il convient pour détecter ADRA1D dans des échantillons de Humain et Rat. Il y a 5+ publications disponibles.
N° du produit ABIN1945085

Aperçu rapide pour ADRA1D anticorps (N-Term) (ABIN1945085)

Antigène

Voir toutes ADRA1D Anticorps
ADRA1D (Adrenergic Receptor, alpha 1d (ADRA1D))

Reactivité

  • 21
  • 14
  • 11
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
Humain, Rat

Hôte

  • 22
Lapin

Clonalité

  • 22
Polyclonal

Conjugué

  • 15
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp ADRA1D est non-conjugé

Application

  • 9
  • 8
  • 6
  • 4
  • 4
  • 3
  • 2
  • 1
Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS)

Clone

RB46798
  • Épitope

    • 5
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-30, N-Term

    Homologie

    M, Rb, B, Dog, Sh

    Purification

    This antibody is purified through a protein A column, followed by peptide affinity purification.

    Immunogène

    This ADRA1D antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 1-30amino acids from the N-terminal region of human ADRA1D.

    Isotype

    IgG
  • Indications d'application

    WB: 1:1000. IHC-P: 1:25. IHC-P: 1:25. IHC-P: 1:25. FC: 1:25

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Date de péremption

    6 months
  • Schwinn, Johnston, Page, Mosley, Wilson, Worman, Campbell, Fidock, Furness, Parry-Smith: "Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues." dans: The Journal of pharmacology and experimental therapeutics, Vol. 272, Issue 1, pp. 134-42, (1995) (PubMed).

    Esbenshade, Hirasawa, Tsujimoto, Tanaka, Yano, Minneman, Murphy: "Cloning of the human alpha 1d-adrenergic receptor and inducible expression of three human subtypes in SK-N-MC cells." dans: Molecular pharmacology, Vol. 47, Issue 5, pp. 977-85, (1995) (PubMed).

    Forray, Bard, Wetzel, Chiu, Shapiro, Tang, Lepor, Hartig, Weinshank, Branchek: "The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype." dans: Molecular pharmacology, Vol. 45, Issue 4, pp. 703-8, (1994) (PubMed).

    Weinberg, Trivedi, Tan, Mitra, Perkins-Barrow, Borkowski, Strader, Bayne: "Cloning, expression and characterization of human alpha adrenergic receptors alpha 1a, alpha 1b and alpha 1c." dans: Biochemical and biophysical research communications, Vol. 201, Issue 3, pp. 1296-304, (1994) (PubMed).

    Bruno, Whittaker, Song, Berelowitz: "Molecular cloning and sequencing of a cDNA encoding a human alpha 1A adrenergic receptor." dans: Biochemical and biophysical research communications, Vol. 179, Issue 3, pp. 1485-90, (1991) (PubMed).

  • Antigène

    ADRA1D (Adrenergic Receptor, alpha 1d (ADRA1D))

    Autre désignation

    ADRA1D

    Sujet

    This alpha-adrenergic receptor mediates its effect through the influx of extracellular calcium.

    Poids moléculaire

    60463

    ID gène

    146

    UniProt

    P25100
Vous êtes ici:
Chat with us!